Risk Factors in Young Middle Eastern Women With Cardiovascular Disease
Classical Risk Factors in Young Middle Eastern Women With Atherosclerotic Cardiovascular Disease
1 other identifier
observational
627
1 country
1
Brief Summary
Cardiovascular disease continues to be the leading cause of death among women in the Middle East, including Jordan. Sex-specific data focused on cardiovascular disease have been increasing steadily, yet is not the subgroup of young women. This study focuses on classical and novel risk factors of cardiovascular disease in young women compared with older women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2021
CompletedFirst Posted
Study publicly available on registry
July 23, 2021
CompletedStudy Start
First participant enrolled
August 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedJanuary 30, 2024
January 1, 2024
2.2 years
July 14, 2021
January 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of classical CVD risk factors
To study the prevalence of the 4 classical risk factors (HTN, DM, smoking, and dyslipidemia) in young women (younger than 50 years of age) who have documented CVD in ambulatory and in-patient settings and compare the data with women older than 50 y of age with CVD.
August 2021 to September 2020.
Secondary Outcomes (1)
Prevalence of novel/emerging CVD risk factors
August 2021 to September 2022.
Study Arms (2)
Young Women
Young women, aged 18 to 50 years, with documented atherosclerotic cardiovascular disease
Older Women
Older women, aged \>50 years, with documented atherosclerotic cardiovascular disease
Interventions
Documenting the presence or absence of CVD risk factors in each participant.
Eligibility Criteria
The prevalence of the 4 classical risk factors (HTN, DM, smoking, and dyslipidemia) will be studied in young women (younger than 50 years of age, and older than 18 y of age) who have documented CVD in ambulatory and in-patient settings. This data will be compared with those from women older than 50 y of age with CVD.
You may qualify if:
- Women aged 18 y or more.
- Documented CVD (CAD stable or ACS, PCI, CABG, CVA/TIA, carotid disease, PAD).
You may not qualify if:
- Women younger than 18 years of age.
- No documented CVD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istishari Hospital
Amman, 11880, Jordan
Related Publications (1)
Hammoudeh AJ, Jallad M, Khader Y, Badaineh Y, Tabbalat RA, Zammar H, Al-Makhamreh H, Basha A, AlAtteili L, Abuhalimeh R, Fkheideh T, Ababneh A, Ababneh L, Mahmoud SA, Alhaddad IA. Atherosclerotic Cardiovascular Disease Novel and Traditional Risk Factors in Middle Eastern Young Women. The ANCORS-YW Study. Glob Heart. 2024 Jul 15;19(1):59. doi: 10.5334/gh.1341. eCollection 2024.
PMID: 39035774DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Reham Nasseddin, MD
Jordan Collaborating Cardiology Group
- STUDY DIRECTOR
Laith N Habahbeh, MD
Jordan Collaborating Cardiology Group
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Interventional Cardiologist, Department of cardiology, Istishari Hospital, Amman, Jordan
Study Record Dates
First Submitted
July 14, 2021
First Posted
July 23, 2021
Study Start
August 22, 2021
Primary Completion
October 30, 2023
Study Completion
October 31, 2023
Last Updated
January 30, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
The individual participant data will be retained with the PI and not shared. Clinical forms with participant initials, rather than full names, will be shared for analysis.